Rangeley Capital »

Vaccitech shares owned by Rangeley Capital

Quarter-by-quarter ownership of Vaccitech (BRNS) shares owned by Rangeley Capital from 13F filings

Historical chart of Rangeley Capital investment in Vaccitech

Tip: Access up to 7 years of quarterly data

All positions including Vaccitech held by Rangeley Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaccitech by Rangeley Capital

Quarter filed Position value Share count Share price at filing
2025-12-31 $59k 84k 0.70

More positions owned by Rangeley Capital

Warner Bros Discovery Com Ser A Call Option (WBD)
Golden Entmt (GDEN)
Calumet (CLMT)
Prothena Corp SHS (PRTA)
Yext (YEXT)
Arvinas Ord (ARVN)
Arbutus Biopharma (ABUS)
Avidity Biosciences Ord (RNA)
Repare Therapeutics Ord
Kennedy-Wilson Holdings (KW)
Seaport Entmt Group Common Stock (SEG)
Delek Us Holdings (DK)
Berto Acquisition Corp Ord Shs (TACO)
Grindr (GRND)
Plymouth Indl Reit

View all positions for Rangeley Capital

Top funds holding Vaccitech

M&G
Sc China Holding
DC Funds
Renaissance Technologies
Johns Hopkins University
Baird Financial
Rangeley Capital
HighTower Advisors
Rhumbline Advisers
Geode Capital Management
UBS Group

View all funds holding Vaccitech